The effect of long-term glycaemic control on serum lipoprotein(a) levels in patients with Type 2 diabetes mellitus. (Q51558534)

7 April 2018

title

The effect of long-term glycaemic control on serum lipoprotein(a) levels in patients with Type 2 diabetes mellitus. (English)

1 reference

7 April 2018

1 reference

1 reference

Song KH

1

1 reference

7 April 2018

Ahn YB

2

1 reference

7 April 2018

Yoon KH

3

1 reference

7 April 2018

Cha BY

4

1 reference

7 April 2018

Lee KW

5

1 reference

7 April 2018

Son HY

6

1 reference

7 April 2018

Kang SK

7

1 reference

7 April 2018

publication date

1 December 1999

1 reference

7 April 2018

published in

Diabetic Medicine

1 reference

7 April 2018

volume

16

1 reference

7 April 2018

issue

12

1 reference

7 April 2018

page(s)

1036-1039

1 reference

7 April 2018

The mysteries of lipoprotein(a)

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

Lipoprotein(a) and Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

Lp(a) concentrations in NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

Lipoprotein(a) concentrations in non-insulin-dependent diabetes mellitus and borderline hyperglycemia: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

Different change in lipoprotein(a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

Lack of Change of Lipoprotein(a) Levels by the Optimization of Glycemic Control With Insulin Therapy in NIDDM Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.1999.00183.X

10.1046/J.1464-5491.1999.00183.X

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

10656233

1 reference

7 April 2018